Choosing wisely: Low-value services, utilization, and patient cost sharing

JAMA

Volumn 308, Issue 16, 2012, Pages 1635-1636

  Volpp, Kevin G ^a,b,c,d   Loewenstein, George ^b,e   Asch, David A ^a,b,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; BACKACHE; COMPUTER ASSISTED TOMOGRAPHY; DRUG COST; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH SERVICE; HIGH RISK POPULATION; HOSPITAL COST; HUMAN; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PRIORITY JOURNAL; RHINOSINUSITIS; SHORT SURVEY; UPPER RESPIRATORY TRACT INFECTION;

EID: 84867696547     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.13616     Document Type: Short Survey

References (8)

1. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801-1802.
2. Choosing Wisely: an initiative of the ABIM Foundation. http://www.choosingwisely.org. Accessed July 30, 2012.
3. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349-2359.
4. Fendrick AM, Chernew ME. Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs. Am J Manag Care. 2006;12(1):18-20.
5. Pauly MV, Held PJ. Benign moral hazard and the cost-effectiveness analysis of insurance coverage. J Health Econ. 1990;9(4):447-461.
6. Choudhry NK, Fischer MA, Avorn J, et al. At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood). 2010;29(11):1995-2001.
7. Choudhry NK, Avorn J, Glynn RJ, et al; Post-Myocardial Infarction Free Rx Event and Economic Evaluation Trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365(22):2088-2097.
8. Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA. 2012; 307(15):1583-1584.